Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Murphy

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
The Journal of Parasitology|January 1, 2008
Early migration of Sarcocystis neurona in ponies fed sporocystsE Elitsur, A E Marsh, S M Reed, et al.
European Review for Medical and Pharmacological Sciences|August 2, 2022
Comparative effectiveness of adding Omega-3 or Vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patientsS M Abdelhalim, J E Murphy, M H Meabed, et al.
Cell|July 10, 1998
Thrombospondin-1 is a major activator of TGF-beta1 in vivoS E Crawford, V Stellmach, J E Murphy-Ullrich, et al.
Human Genetics|May 17, 2001
Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish originM S Silverberg, C Clelland, J E Murphy, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivoL Tang, L Leong, D Sim, et al.
British Journal of Pharmacology|April 23, 2014
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulantsF Cattaruzza, S Amadesi, J F Carlsson, et al.
Experimental Cell Research|May 18, 1999
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1V Pijuan-Thompson, J R Grammer, J Stewart, et al.
European Review for Medical and Pharmacological Sciences|October 31, 2022
Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patientsS M Abdelhalima, J E Murphy, M H Meabed, et al.
Chemistry & Biology|July 8, 1998
Lipitoids--novel cationic lipids for cellular delivery of plasmid DNA in vitroC Y Huang, T Uno, J E Murphy, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2013
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacyA R Brooks, D Sim, U Gritzan, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
The Journal of Parasitology|January 1, 2008
Early migration of Sarcocystis neurona in ponies fed sporocystsE Elitsur, A E Marsh, S M Reed, et al.
European Review for Medical and Pharmacological Sciences|August 2, 2022
Comparative effectiveness of adding Omega-3 or Vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patientsS M Abdelhalim, J E Murphy, M H Meabed, et al.
Cell|July 10, 1998
Thrombospondin-1 is a major activator of TGF-beta1 in vivoS E Crawford, V Stellmach, J E Murphy-Ullrich, et al.
Human Genetics|May 17, 2001
Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish originM S Silverberg, C Clelland, J E Murphy, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivoL Tang, L Leong, D Sim, et al.
British Journal of Pharmacology|April 23, 2014
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulantsF Cattaruzza, S Amadesi, J F Carlsson, et al.
Experimental Cell Research|May 18, 1999
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1V Pijuan-Thompson, J R Grammer, J Stewart, et al.
European Review for Medical and Pharmacological Sciences|October 31, 2022
Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patientsS M Abdelhalima, J E Murphy, M H Meabed, et al.
Chemistry & Biology|July 8, 1998
Lipitoids--novel cationic lipids for cellular delivery of plasmid DNA in vitroC Y Huang, T Uno, J E Murphy, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2013
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacyA R Brooks, D Sim, U Gritzan, et al.
Pageof 19